NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE155973 Query DataSets for GSE155973
Status Public on Dec 07, 2020
Title Macrophage-derived thrombospondin1 promotes obesity-associated non-alcoholic fatty liver disease
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Thrombospondin 1 (TSP1) is a multifunctional matricellular protein. Previously we have shown that TSP1 plays an important role in obesity-associated metabolic complications including inflammation, insulin resistance, cardiovascular and renal disease. However, its contribution to obesity-associated non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) remains largely unknown and is determined in this study. High fat diet or AMLN diet-induced obese and insulin resistant NAFLD/NASH mouse models were utilized. In addition, tissue specific TSP1 knockout mice were utilized to determine the contribution of different cellular sources of obesity-induced TSP1 to NAFLD/NASH development. The data demonstrated that liver TSP1 levels were increased in experimental obese and insulin resistant NAFLD/NASH mouse models as well as in human obese NASH patients. Moreover, TSP1 deletion in hepatocyte or adipocytes did not protect mice from diet-induced NAFLD/NASH. However, myeloid/macrophage-specific TSP1 deletion protected mice against obesity-associated liver injury, accompanied by reduced liver inflammation and fibrosis. Importantly, this protection is independent of the levels of obesity and hepatic steatosis. Mechanistically, through an autocrine effect, macrophage-derived TSP1 suppressed SMPDL3B expression in liver, which amplified liver pro-inflammatory signaling (TLR4 signal pathway) and promoted NAFLD progression. Together, out data suggest that macrophage-derived TSP1 is a significant contributor to obesity-associated NAFLD/NASH development and progression and may serve as a therapeutic target for this disease.
 
Overall design TSP1 floxed mice and macrophage specific TSP1 knockout mice were fed with LF or HF diet for 8 months. Then mie were sacrficed and livers were harvested for further analysis.
 
Contributor(s) Gawg T, Mooli RG, Li D, Lee EY, Wang S
Citation(s) 33294831
https://0-doi-org.brum.beds.ac.uk/10.1016/j.jhepr.2020.100193
Submission date Aug 10, 2020
Last update date Dec 15, 2020
Contact name Shuxia Wang
E-mail(s) swang7@uky.edu
Phone 8592181367
Organization name University of Kentucky
Department Pharmacology and Nutritional Sciences
Street address 900 S. Limestone street, Wethington Bldg. Room 583
City lexington
State/province KY
ZIP/Postal code 40536
Country USA
 
Platforms (1)
GPL23479 BGISEQ-500 (Mus musculus)
Samples (12)
GSM4718405 LF TSP1flox-1
GSM4718406 LF TSP1flox-2
GSM4718407 LF TSP1flox-3
Relations
BioProject PRJNA656249
SRA SRP276889

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE155973_RAW.tar 28.3 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap